Low SLC4A4 expression, which correlates with increased lymph node and distant metastasis, and regulates partial epithelial–mesenchymal transition (EMT) phenotypes that are critical for cancer cell migration and invasion, suggests that SLC4A4 functions as a tumor suppressor gene and serves as a potential prognostic biomarker [18]. This evidence concerns the gene SLC4A4 and cancer.